need to rethink their explanations for why people are hospitalized.
In Manitoba, over the 1998-2001 period, we found residents of the lowest-income urban neighbourhoods to have both more contact with physicians and more hospitalizations than their counterparts in higher-income areas. For six of the nine conditions, individuals living in the lowest-income neighbourhoods had significantly more ambulatory visits before hospitalization than those living in wealthier neighbourhoods -so poorer access to ambulatory care is not the obvious explanation for their high hospitalization rates. Instead, the poor in urban Manitoba had more frequent contact with general practitioners; socioeconomic groups differed little in contact with specialists. What could be responsible for these results? Perhaps residents of lower-income areas see physicians more frequently because they are sicker. Other work has shown children living in low-income neighbourhoods to have less continuity of care than their more affluent counterparts. 1 Those living in low-income areas may visit physicians who manage diseases less appropriately. Residents of poorer neighbourhoods may not be receiving appropriate preventive therapy (i.e., inhaled corticosteroids, which have been shown to decrease hospitalization for asthma). 2 There is some evidence that low-income individuals with pneumonia (independent of comorbidity), are more likely to be hospitalized than to receive initial treatment with antibiotics. 3 Perhaps the poor tend to be noncompliant with appropriate therapy; this Preventing hospitalizations: it's not about access to physicians Links between income, access to primary care, and hospitalization are unclear
Unanswered questions
• Are the findings regarding pneumonia generalizable: do low-income patients receive different treatments (in type or quantity) across a number of these conditions that should be manageable with little or no hospitalization?
• Do the treatments prescribed differ in effectiveness across socioeconomic groups?
• Does the quality of care provided differ between physicians treating the rich and those treating the poor? • Do pharmacists have an impact on the quality of medication treatment across different income populations?
Several studies have demonstrated that pharmacists in primary care settings have both improved the cost effectiveness of drug therapy and improved clinical surrogate markers, patient satisfaction, and quality of life for various populations that have been studied
might be tested by measuring the continuity of use of a designated prescribed drug. Some of these "quality of medication therapy" issues could be managed through the involvement of pharmacists in primary care practices. Several studies have demonstrated that pharmacists in primary care settings have both improved the cost effectiveness of drug therapy and improved clinical surrogate markers, patient satisfaction, and quality of life for various populations that have been studied. [4] [5] [6] [7] [8] Canadian researchers need to go beyond questions of access to physicians and hospitals to better understand the details associated with providing truly equal care. 
